Ashwagandha Supreme: potential presence of undeclared dairy allergens

Product safety

Date

2024-08-27

Country

Canada

Product

Ashwagandha Supreme

Classification

Type I

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2024-08-29
2. CA
   Drugs & medicalType II

   Nasopharyngeal Airway, Double Swivel Connector, 15mm Y Piece, Portex™ Orator Speaking Valve, and Thermovent™ 1200

   Sterility

   Health CanadaOfficial notice →
3. CA
   Drugs & medical

   Importation of US-authorized Epinephrine Injection USP, 1 mg/10 mL Single-Dose Pre-Filled Syringes Due to the Current Shortage of Canadian-Authorized Epinephrine…

   Supply - Dosage - Packaging

   Health CanadaOfficial notice →
4. 2024-08-27
5. CA
   Drugs & medicalType III

   VALACYCLOVIR: Affected lot may contain tablets intended for European market (different embossement)

   Product safety

   Health CanadaOfficial notice →
6. CA
   Drugs & medicalType II

   BD Facsduet™ Sample Preparation Systems

   Performance

   Health CanadaOfficial notice →
7. CA
   Drugs & medicalType II

   Karl Storz Telescopes

   Labelling and packaging - Sterility

   Health CanadaOfficial notice →
8. CA
   Drugs & medical

   Unauthorized UMARY Hyaluronic Acid Dietary Supplement contains undeclared prescription drugs and may pose serious health risks

   Undeclared substance

   Health CanadaOfficial notice →